Regeneron Pharmaceuticals... (REGN)
NASDAQ: REGN
· Real-Time Price · USD
493.12
10.05 (2.08%)
At close: Jun 06, 2025, 3:59 PM
494.76
0.33%
After-hours: Jun 06, 2025, 05:59 PM EDT
Regeneron Pharmaceuticals Revenue
Regeneron Pharmaceuticals reported an annual revenue of $14.2B, reflecting a 8.27% growth. For the quarter ending March 31, 2025, Regeneron Pharmaceuticals generated $3.03B in revenue.
Revenue (ttm)
$14.2B
Revenue Growth
8.27%
Price / Sales Ratio
5.41
Revenue / Employee
$936.93K
Employees
15,158
Market Cap
52.34B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|